查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1466331

治疗药物监测市场：按产品、技术、药物类别和最终用户 - 2024-2030 年全球预测

Therapeutic Drug Monitoring Market by Product (Consumables, Data Management Services, Equipment), Technology (Chromatography-MS, Immunoassays, Proteomic Technologies), Drug Class, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年治疗药物监测市场规模为37.9亿美元，预计2024年将达43.8亿美元，2030年将达到107.8亿美元，复合年增长率为16.11%。

治疗药物监测是一种测量血浆、血清和血液中药物浓度的实验室检验过程。这些治疗药物监测过程允许设计患者特定的给药方案、优化药物功效以及维持患者体内药物物质的恆定水平。慢性病的增加以及医疗保健和製药行业的发展产生了对治疗药物监测的需求，以有效监测药物的安全性和有效性。然而，熟练的实验室技术人员数量有限和报销政策不佳正在阻碍市场成长。此外，免疫测量和其他治疗药物监测技术的市场开拓正在创造市场成长机会。

主要市场统计
基准年[2023] 37.9亿美元
预测年份 [2024] 43.8亿美元
预测年份 [2030] 107.8亿美元
复合年增长率（%） 16.11%

产品高效药品管理对资料管理服务的需求不断增长

消耗品包括试剂、套件、校准曲线和其他一次性物品，这些物品对于提高药物水平测试的准确性至关重要，并且由于重复使用而需求量很大。资料管理服务至关重要，它提供先进的解决方案来有效处理从 TDM 流程中获得的大量资料。它还包括专为资料收集、分析和报告而设计的软体和系统，以确保简化关键患者和治疗资讯的管理。设备领域包括用于特异性和灵敏药物检测的层析法和质谱检测器、用于各种生物化学检验的临床化学分析仪以及用于快速有效的药物定量的免疫检测分析仪，包括各种分析仪和检测器。

最终用户：医院的需求不断增长，准确的药品管理至关重要

医院实验室有助于完善患者照护，特别是对于由于治疗指数窄、毒性高或药物代谢和作用的个体差异而需要精确剂量的治疗。这种方法在急诊环境和肿瘤学和移植医学等专业中至关重要，其中精确的药物管理对于患者的生存和康復至关重要。私人实验室为更广泛的门诊病人提供服务，与初级保健和专家密切合作，管理心理健康、心血管疾病和自体免疫疾病等长期疾病。私人实验室提供及时的药物水平评估，并指导医生做出有关剂量变化和药物选择的明智决定，帮助为患者量身定制有效的治疗计划，已成为实现这一目标的重要组成部分。

区域洞察

由于对器官移植的需求不断增长、精准医疗的使用以及 TDM 在医疗保健领域（包括医院和商业实验室）的应用，美洲的市场格局正在迅速发展。慢性病盛行率的上升以及消费者对个人化药物治疗的偏好日益增加，显着增加了亚太地区和欧洲、中东和非洲地区药物开发过程中对治疗药物监测的需求。欧洲各国政府正在将重点转向推出研发框架计划，旨在开发新的个人化药物，从而增加投资和资金筹措。世界各国政府都致力于加速开发各类药物的基因组研究活动，认识到 TDM 的临床益处将有助于最大限度地减少药物副作用并改善治疗结果，预计世界各地医院对 TDM 的需求将会增加。得到

FPNV定位矩阵

FPNV定位矩阵对于评估治疗药物监测市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对治疗药物监测市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，以获得市场竞争优势。

本报告在以下方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4. 竞争评估和情报：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.治疗药物监测市场的市场规模与预测为何？

2.治疗药物监测市场预测期内需要考虑投资的产品、细分市场、应用和领域有哪些？

3.治疗药物监测市场的技术趋势和法规结构是什么？

4.治疗药物监测市场主要厂商的市场占有率为何？

5. 进入治疗药物监测市场的适当型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 对个人化医疗的需求不断增加
      • 在各个治疗领域更常采用治疗药物监测
      • 在固态器官移植患者的使用和重要性不断增加
    • 抑制因素
      • 退款政策不佳
      • 需要大量资本投资
    • 机会
      • 开发中国家治疗药物监测的未来前景
      • 免疫检测和其他治疗药物监测技术的进展
    • 任务
      • 临床挑战和熟练实验室技术人员的短缺
  • 市场区隔分析
    • 产品：对资料管理服务的需求不断增长，以实现高效的药物管理
    • 最终用户：医院的需求不断增长，准确的药品管理至关重要
  • 市场趋势分析
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法规结构分析
  • 客户客製化

第六章治疗药物监测市场：副产品

  • 消耗品
  • 资料管理服务
  • 装置

第七章治疗药物监测市场：依技术分类

  • 层析法-MS
  • 免疫学测试
  • 蛋白质体技术

第八章按药物类别分類的治疗药物监测市场

  • 抗心律不整药物
  • 抗生素
  • 抗癫痫药
  • 支气管扩张剂
  • 免疫抑制药物
  • 精神药物

第九章治疗药物监测市场：依最终使用者分类

  • 医院实验室
  • 私人实验室

第十章美洲治疗药物监测市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区治疗药物监测市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的治疗药物监测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争场景分析
    • Capitainer 宣布与阿斯特捷利康建立合作关係。
    • Novo Holdings 投资蛋白质体学技术公司 Evosep。
    • AegirBio AB 已与 Atlas Special Opportunities, LLC 签署协议，发行 5,500 万瑞典克朗带认股权证的可转换债券，以加强其在 TDM、唾液样本采集等领域的投资。
    • 用于治疗药物监测分析的临床 LC-MS 方法。
    • Boditech Med已获得四种TDM产品的出口许可。
    • Pace 检测戴奥辛和二苯并呋喃的 GC-MS/MS 技术已获得 EPA核准。
    • Bio-Rad 扩大了用于生物分析和药物监测的抗个体遗传型抗体的产品范围。
    • Beckman Coulter 和 Saladax Biomedical 在抗精神病药物监测方面合作。
    • Ampersand Capital Partners 投资了领先的 SIFT-MS解决方案供应商Syft Technologies。

第14章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-A77F2EE7AB43

[196 Pages Report] The Therapeutic Drug Monitoring Market size was estimated at USD 3.79 billion in 2023 and expected to reach USD 4.38 billion in 2024, at a CAGR 16.11% to reach USD 10.78 billion by 2030.

Therapeutic drug monitoring is the clinical testing process of measuring plasma, serum, or blood drug concentrations. These therapeutic drug monitoring processes enable designing the patient-specific dosage regimen, optimizing the effectiveness of drugs, and maintaining a certain level of drug substance in patients' bodies. The increase in chronic disease incidences and growth in the healthcare and pharmaceutical industries create the need for therapeutic drug monitoring to monitor drug dosage safety and efficacy effectively. However, the limited availability of skilled laboratory technicians and inadequate reimbursement policies is hampering the growth of the market. Furthermore, the developments in immunoassay and other therapeutic drug monitoring technologies are creating opportunities for market growth.

KEY MARKET STATISTICS
Base Year [2023] USD 3.79 billion
Estimated Year [2024] USD 4.38 billion
Forecast Year [2030] USD 10.78 billion
CAGR (%) 16.11%

Product: Rising demand for data management services for efficient drug management

Consumables include indispensable disposable items such as reagents, kits, and calibrators, crucial for the accuracy of drug-level tests, and witness a growing demand due to their repetitive use. Data management services are pivotal, offering advanced solutions for efficiently handling the extensive data yielded from TDM processes, including software and systems designed for data collection, analysis, and reporting, ensuring streamlined management of crucial patient and treatment information. The equipment segment encompasses various analyzers and detectors, such as chromatography & MS Detectors for specific and sensitive drug detection, clinical chemistry analyzers for broad biochemical testing, and immunoassay analyzers for quick and effective drug quantification.

End-User: Increasing demand from hospitals where accurate drug management is essential

Hospital labs are instrumental in refining patient care, particularly for treatments requiring precise dosing due to the narrow therapeutic index, high toxicity, or individual variations in drug metabolism and action. This approach is essential in acute care scenarios and specialties such as oncology and transplant medicine, where accurate drug management is crucial to patient survival and recovery. Private laboratories cater to a broader outpatient population, collaborating closely with primary care and specialty physicians to manage long-term conditions, including mental health, cardiovascular, and autoimmune diseases. Private laboratories provide timely drug-level assessments and are indispensable in guiding physicians toward making educated decisions on dosage modifications and medication selection, thereby ensuring tailored and efficacious patient treatment plans.

Regional Insights

The therapeutic drug monitoring market shows a highly evolving landscape in the Americas owing to the increasing demand for organ transplantation, usage of precision medicines, and applications of TDM in healthcare areas, including hospital labs and private labs. The rising prevalence of chronic diseases, and increasing consumer switch towards personalized medications, tremendously increase the demand for therapeutic drug monitoring for drug development process in APAC and EMEA regions. European governments have shifted their focus towards launching the Framework Programme for Research and Technological Development, which aims to develop new personalized medicine leading to a rise in investment and funding. Governments worldwide are focusing on accelerating genomic research activities for the development of different types of drugs, and recognizing the clinical benefits of therapeutic drug monitoring is expected to raise demand for TDM from hospitals worldwide for better treatment outcomes with minimum side effects from the medication.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Therapeutic Drug Monitoring Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Therapeutic Drug Monitoring Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Therapeutic Drug Monitoring Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., apDia Group, ARK Diagnostics, Inc., ARUP Laboratories, Assay Genie, Bio-Rad Laboratories, Inc., bioMerieux SA, Buhlmann Laboratories AG, Cambridge Life Sciences Limited, Cardinal Health, Inc., Chromsystems Instruments & Chemicals GmbH, Danaher Corporation, DiaSorin SpA, DiaSystem Scandinavia AB, Eagle Biosciences, Inc., Exagen Inc., F. Hoffmann-La Roche AG, Grifols, S.A., H.U. Group Holdings, Inc., Krishgen Biosystems, Merck KGaA, Myriad Genetics, Inc., Neoteryx, LLC by Trajan Group, OneCare Media, LLC, Pfizer Inc., R-Biopharm AG, Randox Laboratories, Ltd., Sekisui Chemical Co Ltd., Siemens Healthineers AG, Svar Life Science AB, Tecan Trading AG, Theradiag SA, Thermo Fisher Scientific, Inc., and Veolia Group.

Market Segmentation & Coverage

This research report categorizes the Therapeutic Drug Monitoring Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Consumables
    • Data Management Services
    • Equipment
      • Chromatography & MS Detectors
      • Clinical Chemistry Analyzers
      • Immunoassay Analyzers
  • Technology
    • Chromatography-MS
      • GC-MS
      • LC-MS
    • Immunoassays
      • Chemiluminescence Immunoassays
      • Colorimetric Immunoassays
      • Fluorescence Immunoassays
      • Radioimmunoassays
    • Proteomic Technologies
  • Drug Class
    • Antiarrhythmic Drugs
    • Antibiotic Drugs
    • Antiepileptic Drugs
    • Bronchodilator Drugs
    • Immunosuppressant Drugs
    • Psychoactive Drugs
  • End-User
    • Hospital Labs
    • Private Labs
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Therapeutic Drug Monitoring Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Therapeutic Drug Monitoring Market?

3. What are the technology trends and regulatory frameworks in the Therapeutic Drug Monitoring Market?

4. What is the market share of the leading vendors in the Therapeutic Drug Monitoring Market?

5. Which modes and strategic moves are suitable for entering the Therapeutic Drug Monitoring Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increased Demand for Personalized Medicine
      • 5.1.1.2. Rising Adoption of Therapeutic Drug Monitoring Across Various Therapeutic Fields
      • 5.1.1.3. Growing Use and Importance in Patients with Solid Organ Transplantation
    • 5.1.2. Restraints
      • 5.1.2.1. Inadequate Reimbursement Policies
      • 5.1.2.2. Need of High Capital Investments
    • 5.1.3. Opportunities
      • 5.1.3.1. Future Perspectives of Therapeutic Drug Monitoring in Developing Nations
      • 5.1.3.2. Developments in Immunoassay and Other Therapeutic Drug Monitoring Technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Clinical Challenges and Limited Availability of Skilled Laboratory Technicians
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Rising demand for data management services for efficient drug management
    • 5.2.2. End-User: Increasing demand from hospitals where accurate drug management is essential
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis
  • 5.9. Client Customization

6. Therapeutic Drug Monitoring Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Data Management Services
  • 6.4. Equipment

7. Therapeutic Drug Monitoring Market, by Technology

  • 7.1. Introduction
  • 7.2. Chromatography-MS
  • 7.3. Immunoassays
  • 7.4. Proteomic Technologies

8. Therapeutic Drug Monitoring Market, by Drug Class

  • 8.1. Introduction
  • 8.2. Antiarrhythmic Drugs
  • 8.3. Antibiotic Drugs
  • 8.4. Antiepileptic Drugs
  • 8.5. Bronchodilator Drugs
  • 8.6. Immunosuppressant Drugs
  • 8.7. Psychoactive Drugs

9. Therapeutic Drug Monitoring Market, by End-User

  • 9.1. Introduction
  • 9.2. Hospital Labs
  • 9.3. Private Labs

10. Americas Therapeutic Drug Monitoring Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Therapeutic Drug Monitoring Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Therapeutic Drug Monitoring Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Capitainer announces collaboration with AstraZeneca.
    • 13.3.2. Novo Holdings invests in proteomics technology company, Evosep.
    • 13.3.3. AegirBio AB enters into an agreement with Atlas Special Opportunities, LLC regarding convertible bonds of SEK 55 million with attached warrants to intensify investments in i.a. TDM and saliva sampling.
    • 13.3.4. Clinical LC-MS methods for therapeutic drug monitoring analysis.
    • 13.3.5. Boditech Med has obtained the export license of four TDM products.
    • 13.3.6. Pace Obtains EPA Approval on Method for Detecting Dioxins and Dibenzofurans Through GC-MS/MS Technology.
    • 13.3.7. Bio-Rad Extends Range of Anti-Idiotypic Antibodies for Bioanalysis and Drug Monitoring.
    • 13.3.8. Beckman Coulter and Saladax Biomedical Team Up on Antipsychotic Therapeutic Drug Monitoring.
    • 13.3.9. Ampersand Capital Partners Invests in Syft Technologies, Leading SIFT-MS Solutions Provider.

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. THERAPEUTIC DRUG MONITORING MARKET RESEARCH PROCESS
  • FIGURE 2. THERAPEUTIC DRUG MONITORING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. THERAPEUTIC DRUG MONITORING MARKET DYNAMICS
  • FIGURE 7. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. THERAPEUTIC DRUG MONITORING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. THERAPEUTIC DRUG MONITORING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. THERAPEUTIC DRUG MONITORING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CONSUMABLES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DATA MANAGEMENT SERVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DATA MANAGEMENT SERVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY & MS DETECTORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY & MS DETECTORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CLINICAL CHEMISTRY ANALYZERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CLINICAL CHEMISTRY ANALYZERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY GC-MS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY GC-MS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY LC-MS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY LC-MS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAYS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAYS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY COLORIMETRIC IMMUNOASSAYS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY COLORIMETRIC IMMUNOASSAYS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY FLUORESCENCE IMMUNOASSAYS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY FLUORESCENCE IMMUNOASSAYS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY RADIOIMMUNOASSAYS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY RADIOIMMUNOASSAYS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PROTEOMIC TECHNOLOGIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PROTEOMIC TECHNOLOGIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY ANTIARRHYTHMIC DRUGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY ANTIARRHYTHMIC DRUGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY ANTIBIOTIC DRUGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY ANTIBIOTIC DRUGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY ANTIEPILEPTIC DRUGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY ANTIEPILEPTIC DRUGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY BRONCHODILATOR DRUGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY BRONCHODILATOR DRUGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOSUPPRESSANT DRUGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOSUPPRESSANT DRUGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PSYCHOACTIVE DRUGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PSYCHOACTIVE DRUGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 63. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY HOSPITAL LABS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 64. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY HOSPITAL LABS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 65. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRIVATE LABS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 66. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRIVATE LABS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 67. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 68. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 71. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 72. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 73. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2023 (USD MILLION)
  • TABLE 74. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2024-2030 (USD MILLION)
  • TABLE 75. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2023 (USD MILLION)
  • TABLE 76. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2024-2030 (USD MILLION)
  • TABLE 77. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 78. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 79. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 80. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 81. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 82. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 83. ARGENTINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 84. ARGENTINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 85. ARGENTINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 86. ARGENTINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 87. ARGENTINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 88. ARGENTINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 89. ARGENTINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2023 (USD MILLION)
  • TABLE 90. ARGENTINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2024-2030 (USD MILLION)
  • TABLE 91. ARGENTINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2023 (USD MILLION)
  • TABLE 92. ARGENTINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2024-2030 (USD MILLION)
  • TABLE 93. ARGENTINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 94. ARGENTINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 95. ARGENTINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 96. ARGENTINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 97. BRAZIL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 98. BRAZIL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 99. BRAZIL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 100. BRAZIL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 101. BRAZIL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 102. BRAZIL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 103. BRAZIL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2023 (USD MILLION)
  • TABLE 104. BRAZIL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2024-2030 (USD MILLION)
  • TABLE 105. BRAZIL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2023 (USD MILLION)
  • TABLE 106. BRAZIL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2024-2030 (USD MILLION)
  • TABLE 107. BRAZIL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 108. BRAZIL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 109. BRAZIL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 110. BRAZIL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 111. CANADA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 112. CANADA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 113. CANADA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 114. CANADA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 115. CANADA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 116. CANADA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 117. CANADA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2023 (USD MILLION)
  • TABLE 118. CANADA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2024-2030 (USD MILLION)
  • TABLE 119. CANADA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2023 (USD MILLION)
  • TABLE 120. CANADA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2024-2030 (USD MILLION)
  • TABLE 121. CANADA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 122. CANADA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 123. CANADA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 124. CANADA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 125. MEXICO THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 126. MEXICO THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 127. MEXICO THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 128. MEXICO THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 129. MEXICO THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 130. MEXICO THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 131. MEXICO THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2023 (USD MILLION)
  • TABLE 132. MEXICO THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2024-2030 (USD MILLION)
  • TABLE 133. MEXICO THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2023 (USD MILLION)
  • TABLE 134. MEXICO THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2024-2030 (USD MILLION)
  • TABLE 135. MEXICO THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 136. MEXICO THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 137. MEXICO THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 138. MEXICO THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 139. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 140. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 141. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 142. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 143. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 144. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 145. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2023 (USD MILLION)
  • TABLE 146. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2024-2030 (USD MILLION)
  • TABLE 147. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2023 (USD MILLION)
  • TABLE 148. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2024-2030 (USD MILLION)
  • TABLE 149. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 150. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 151. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 152. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 153. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 154. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2023 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2024-2030 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2023 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2024-2030 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 171. AUSTRALIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 172. AUSTRALIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 173. AUSTRALIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 174. AUSTRALIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 175. AUSTRALIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 176. AUSTRALIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 177. AUSTRALIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2023 (USD MILLION)
  • TABLE 178. AUSTRALIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2024-2030 (USD MILLION)
  • TABLE 179. AUSTRALIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2023 (USD MILLION)
  • TABLE 180. AUSTRALIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2024-2030 (USD MILLION)
  • TABLE 181. AUSTRALIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 182. AUSTRALIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 183. AUSTRALIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 184. AUSTRALIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 185. CHINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 186. CHINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 187. CHINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 188. CHINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 189. CHINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 190. CHINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 191. CHINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2023 (USD MILLION)
  • TABLE 192. CHINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2024-2030 (USD MILLION)
  • TABLE 193. CHINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2023 (USD MILLION)
  • TABLE 194. CHINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2024-2030 (USD MILLION)
  • TABLE 195. CHINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 196. CHINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 197. CHINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 198. CHINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 199. INDIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 200. INDIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 201. INDIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 202. INDIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 203. INDIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 204. INDIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 205. INDIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2023 (USD MILLION)
  • TABLE 206. INDIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2024-2030 (USD MILLION)
  • TABLE 207. INDIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2023 (USD MILLION)
  • TABLE 208. INDIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2024-2030 (USD MILLION)
  • TABLE 209. INDIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 210. INDIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 211. INDIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 212. INDIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 213. INDONESIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 214. INDONESIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 215. INDONESIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 216. INDONESIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 217. INDONESIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 218. INDONESIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 219. INDONESIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2023 (USD MILLION)
  • TABLE 220. INDONESIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2024-2030 (USD MILLION)
  • TABLE 221. INDONESIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2023 (USD MILLION)
  • TABLE 222. INDONESIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2024-2030 (USD MILLION)
  • TABLE 223. INDONESIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 224. INDONESIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 225. INDONESIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 226. INDONESIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 227. JAPAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 228. JAPAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 229. JAPAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 230. JAPAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 231. JAPAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 232. JAPAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 233. JAPAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2023 (USD MILLION)
  • TABLE 234. JAPAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2024-2030 (USD MILLION)
  • TABLE 235. JAPAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2023 (USD MILLION)
  • TABLE 236. JAPAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2024-2030 (USD MILLION)
  • TABLE 237. JAPAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 238. JAPAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 239. JAPAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 240. JAPAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 241. MALAYSIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 242. MALAYSIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 243. MALAYSIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 244. MALAYSIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 245. MALAYSIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 246. MALAYSIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 247. MALAYSIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2023 (USD MILLION)
  • TABLE 248. MALAYSIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2024-2030 (USD MILLION)
  • TABLE 249. MALAYSIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2023 (USD MILLION)
  • TABLE 250. MALAYSIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2024-2030 (USD MILLION)
  • TABLE 251. MALAYSIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 252. MALAYSIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 253. MALAYSIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 254. MALAYSIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 255. PHILIPPINES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 256. PHILIPPINES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 257. PHILIPPINES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 258. PHILIPPINES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 259. PHILIPPINES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 260. PHILIPPINES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 261. PHILIPPINES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2023 (USD MILLION)
  • TABLE 262. PHILIPPINES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2024-2030 (USD MILLION)
  • TABLE 263. PHILIPPINES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2023 (USD MILLION)
  • TABLE 264. PHILIPPINES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2024-2030 (USD MILLION)
  • TABLE 265. PHILIPPINES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 266. PHILIPPINES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 267. PHILIPPINES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 268. PHILIPPINES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 269. SINGAPORE THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 270. SINGAPORE THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 271. SINGAPORE THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 272. SINGAPORE THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 273. SINGAPORE THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 274. SINGAPORE THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 275. SINGAPORE THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2023 (USD MILLION)
  • TABLE 276. SINGAPORE THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2024-2030 (USD MILLION)
  • TABLE 277. SINGAPORE THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2023 (USD MILLION)
  • TABLE 278. SINGAPORE THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2024-2030 (USD MILLION)
  • TABLE 279. SINGAPORE THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 280. SINGAPORE THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 281. SINGAPORE THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 282. SINGAPORE THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 283. SOUTH KOREA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 284. SOUTH KOREA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 285. SOUTH KOREA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 286. SOUTH KOREA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 287. SOUTH KOREA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 288. SOUTH KOREA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 289. SOUTH KOREA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2023 (USD MILLION)
  • TABLE 290. SOUTH KOREA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2024-2030 (USD MILLION)
  • TABLE 291. SOUTH KOREA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2023 (USD MILLION)
  • TABLE 292. SOUTH KOREA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2024-2030 (USD MILLION)
  • TABLE 293. SOUTH KOREA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 294. SOUTH KOREA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 295. SOUTH KOREA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 296. SOUTH KOREA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 297. TAIWAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 298. TAIWAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 299. TAIWAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 300. TAIWAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 301. TAIWAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 302. TAIWAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 303. TAIWAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2023 (USD MILLION)
  • TABLE 304. TAIWAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2024-2030 (USD MILLION)
  • TABLE 305. TAIWAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2023 (USD MILLION)
  • TABLE 306. TAIWAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2024-2030 (USD MILLION)
  • TABLE 307. TAIWAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 308. TAIWAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 309. TAIWAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 310. TAIWAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 311. THAILAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 312. THAILAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 313. THAILAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 314. THAILAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 315. THAILAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 316. THAILAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 317. THAILAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2023 (USD MILLION)
  • TABLE 318. THAILAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2024-2030 (USD MILLION)
  • TABLE 319. THAILAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2023 (USD MILLION)
  • TABLE 320. THAILAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2024-2030 (USD MILLION)
  • TABLE 321. THAILAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2